NCT06247189View on ClinicalTrials.gov

ICOPE Program Feasibility in the Management of Myeloma Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
FrailtyMultiple Myeloma
Interventions
OTHER

ICOPE Monitoring

"At inclusion set up of the ICOPE monitor program on the patient's device and evaluation (all steps) of ICOPE Monitor program.~Monthly, re-evaluation of the patient (Step 1 and others if necessary ) according to the ICOPE Monitor program"

Trial Locations (1)

Unknown

CHU de Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT06247189 - ICOPE Program Feasibility in the Management of Myeloma Patients | Biotech Hunter | Biotech Hunter